Catalina Resources (ASX:CTN) is preparing to refine its Evanston gold project’s mineralisation model, with new Phase 1 RC ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...
It's simple, right? Not so ...
This market reminds me of 2023, when a prominent Wall Street analyst went all in on the impact of GLP-1s. I'm not going to name the analyst — just too vicious — but the gist of the report was that ...